These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 12675505

  • 1. Medical management of thyrotropin-secreting pituitary adenomas.
    Beck-Peccoz P, Persani L.
    Pituitary; 2002; 5(2):83-8. PubMed ID: 12675505
    [Abstract] [Full Text] [Related]

  • 2.
    Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Beck-Peccoz P, Persani L, Lania A.
    ; 2000. PubMed ID: 25905212
    [Abstract] [Full Text] [Related]

  • 3. Pituitary tumours: TSH-secreting adenomas.
    Beck-Peccoz P, Persani L, Mannavola D, Campi I.
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):597-606. PubMed ID: 19945025
    [Abstract] [Full Text] [Related]

  • 4. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas.
    Gancel A, Vuillermet P, Legrand A, Catus F, Thomas F, Kuhn JM.
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):421-8. PubMed ID: 8187308
    [Abstract] [Full Text] [Related]

  • 5. Surgical management of thyrotropin-secreting pituitary adenomas.
    Losa M, Mortini P, Franzin A, Barzaghi R, Mandelli C, Giovanelli M.
    Pituitary; 1999 Aug; 2(2):127-31. PubMed ID: 11081163
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis and treatment of pituitary adenomas.
    Chanson P, Salenave S.
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [Abstract] [Full Text] [Related]

  • 7. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature.
    Kienitz T, Quinkler M, Strasburger CJ, Ventz M.
    Eur J Endocrinol; 2007 Jul; 157(1):39-46. PubMed ID: 17609400
    [Abstract] [Full Text] [Related]

  • 8. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F, Grunenwald S, Vezzosi D, Rivière LD, Bennet A, Caron P.
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [Abstract] [Full Text] [Related]

  • 9. Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report.
    Yang J, Liu S, Yang Z, Shi YB.
    Medicine (Baltimore); 2017 Dec; 96(50):e8912. PubMed ID: 29390279
    [Abstract] [Full Text] [Related]

  • 10. [Thyrotropin-secreting pituitary adenomas].
    Caron P.
    Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
    [Abstract] [Full Text] [Related]

  • 11. [Thyrotropin--TSH secreting pituitary tumor].
    Zieliński G, Podgórski JK, Warczyńska A, Koziarski A, Zgliczyński W.
    Przegl Lek; 2002 Jan; 59(12):1018-23. PubMed ID: 12731380
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
    [Abstract] [Full Text] [Related]

  • 14. Long term treatment of a thyrotropin-secreting microadenoma with somatostatin analogues.
    Prieto-Tenreiro A, Díaz-Guardiola P.
    Arq Bras Endocrinol Metabol; 2010 Apr; 54(5):502-6. PubMed ID: 20694413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.
    Sanno N, Teramoto A, Osamura RY.
    J Neurooncol; 2001 Sep; 54(2):179-86. PubMed ID: 11761434
    [Abstract] [Full Text] [Related]

  • 17. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.
    Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A.
    Eur J Endocrinol; 2003 Apr; 148(4):433-42. PubMed ID: 12656664
    [Abstract] [Full Text] [Related]

  • 18. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.
    Mannavola D, Persani L, Vannucchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):176-81. PubMed ID: 15670193
    [Abstract] [Full Text] [Related]

  • 19. Response of thyrotropin-secreting pituitary tumors to preoperative lanreotide therapy. Report of two cases.
    Tokutsu A, Okada Y, Torimoto K, Otsuka T, Narisawa M, Kurozumi A, Tanaka Y.
    Neuro Endocrinol Lett; 2020 Apr; 41(1):10-16. PubMed ID: 32338854
    [Abstract] [Full Text] [Related]

  • 20. Reduction in size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
    Lee EJ, Kim KR, Lim SK, Lee HC, Kim DI, Kim SH, Huh KB.
    Eur J Endocrinol; 1994 Jul; 131(1):109-12. PubMed ID: 8038902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.